Type |
Details |
Score |
Strain |
Attribute String: |
mutant stock, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alkal2/Alkal2 |
Background: |
C57BL/6NJ-Alkal2/Mmjax |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
501
|
Fragment?: |
false |
|
•
•
•
•
•
|
Allele |
Name: |
anaplastic lymphoma kinase; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Publication |
First Author: |
Defaye M |
Year: |
2022 |
Journal: |
J Clin Invest |
Title: |
The neuronal tyrosine kinase receptor ligand ALKAL2 mediates persistent pain. |
Volume: |
132 |
Issue: |
12 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang H |
Year: |
2014 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome. |
Volume: |
111 |
Issue: |
44 |
Pages: |
15741-5 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alkal2/Alkal2<+> |
Background: |
C57BL/6NJ-Alkal2/Mmjax |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
481
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Reshetnyak AV |
Year: |
2018 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α). |
Volume: |
115 |
Issue: |
33 |
Pages: |
8340-8345 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
140
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
168
|
Fragment?: |
false |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 5, Hiroaki Honda |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 9, Hiroaki Honda |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Allele |
Name: |
collagen, type I, alpha 1; targeted mutation 1, Kwok-Kin Wong |
Allele Type: |
Targeted |
Attribute String: |
Humanized sequence, Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
DO Term |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Z |
Year: |
2010 |
Journal: |
Cancer Res |
Title: |
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene. |
Volume: |
70 |
Issue: |
23 |
Pages: |
9827-36 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
2312
|
Fragment?: |
false |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 2, Louis Chesler |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 60, Johannes H Schulte |
Allele Type: |
Transgenic |
Attribute String: |
Conditional ready, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
anaplastic lymphoma kinase; targeted mutation 1, Stephan W Morris |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1100
|
Fragment?: |
false |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alk/Alk |
Background: |
involves: 129P2/OlaHsd * C57BL/6J |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alk/Alk |
Background: |
involves: 129P2/OlaHsd |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Allele |
Name: |
anaplastic lymphoma kinase; targeted mutation 1.1, Hideki Enomoto |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Col1a1/Col1a1<+> Tg(Scgb1a1-rtTA)1Jaw/? |
Background: |
involves: 129 * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alk/Alk Ltk/Ltk |
Background: |
involves: 129 * 129P2/OlaHsd |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Bassermann F |
Year: |
2005 |
Journal: |
Cell |
Title: |
NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry. |
Volume: |
122 |
Issue: |
1 |
Pages: |
45-57 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry contains Nuclear-interacting partner of ALK (NIPA) and NIPA like proteins, as well as mRNA export factor Rsm1, all of which contain a C3HC-type zinc finger. The domain represented in this entry is found C-terminal to the zinc-finger like domain . Rsm1 is involved in mRNA export from the nucleus []. NIPA is an essential component of an SCF-type E3 ligase complex, SCF(NIPA), a complex that controls mitotic entry by mediating ubiquitination and subsequent degradation of cyclin B1 (CCNB1). Its cell-cycle-dependent phosphorylation regulates the assembly of the SCF(NIPA) complex, restricting CCNB1 ubiquitination activity to interphase. Its inactivation results in nuclear accumulation of CCNB1 in interphase and premature mitotic entry []. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1233
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
428
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
770
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
595
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Cohen MA |
Year: |
2020 |
Journal: |
Cell Stem Cell |
Title: |
Formation of Human Neuroblastoma in Mouse-Human Neural Crest Chimeras. |
Volume: |
26 |
Issue: |
4 |
Pages: |
579-592.e6 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Th-ALK*F1174L)2Loch/? Tg(Th-MYCN)41Waw/? |
Background: |
involves: 129X1/SvJ * BALB/c * C57BL/6J * CBA |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-Alk*F1174L,-luc)60Jhsc/? Tg(Dbh-icre)1Gsc/? |
Background: |
involves: C57BL/6 * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-Alk*F1174L,-luc)60Jhsc/? Th/Th<+> |
Background: |
involves: 129X1/SvJ * C57BL/6 * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
Baseline |
Source: |
GEO |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
488
|
Fragment?: |
false |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-Alk*F1174L,-luc)60Jhsc/? Tg(Dbh-icre)1Gsc/? Tg(Th-MYCN)41Waw/? |
Background: |
involves: 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alk/Alk |
Background: |
involves: 129X1/SvJ * C57BL/6 * C57BL/6N * SJL |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alk/Alk Tg(Mpz-cre)94Imeg/? |
Background: |
involves: 129X1/SvJ * C57BL/6 * C57BL/6N * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Lastwika KJ |
Year: |
2016 |
Journal: |
Cancer Res |
Title: |
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer. |
Volume: |
76 |
Issue: |
2 |
Pages: |
227-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chiarle R |
Year: |
2005 |
Journal: |
Nat Med |
Title: |
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. |
Volume: |
11 |
Issue: |
6 |
Pages: |
623-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang S |
Year: |
2012 |
Journal: |
Cell |
Title: |
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling. |
Volume: |
151 |
Issue: |
5 |
Pages: |
937-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yanagisawa H |
Year: |
2010 |
Journal: |
Neurosci Res |
Title: |
Pleiotrophin induces neurite outgrowth and up-regulates growth-associated protein (GAP)-43 mRNA through the ALK/GSK3beta/beta-catenin signaling in developing mouse neurons. |
Volume: |
66 |
Issue: |
1 |
Pages: |
111-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Agrotis A |
Year: |
1996 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Vascular smooth muscle cells express multiple type I receptors for TGF-beta, activin, and bone morphogenetic proteins. |
Volume: |
219 |
Issue: |
2 |
Pages: |
613-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ardini E |
Year: |
2010 |
Journal: |
Cancer Lett |
Title: |
Anaplastic Lymphoma Kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy. |
Volume: |
299 |
Issue: |
2 |
Pages: |
81-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mano H |
Year: |
2012 |
Journal: |
Cancer Discov |
Title: |
ALKoma: a cancer subtype with a shared target. |
Volume: |
2 |
Issue: |
6 |
Pages: |
495-502 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tucker ER |
Year: |
2015 |
Journal: |
Cancer Res |
Title: |
Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric Clinic. |
Volume: |
75 |
Issue: |
14 |
Pages: |
2770-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wong CO |
Year: |
2015 |
Journal: |
Cell Rep |
Title: |
Diminished MTORC1-Dependent JNK Activation Underlies the Neurodevelopmental Defects Associated with Lysosomal Dysfunction. |
Volume: |
12 |
Issue: |
12 |
Pages: |
2009-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giaccone G |
Year: |
2023 |
Journal: |
Semin Cancer Biol |
Title: |
Current knowledge of small cell lung cancer transformation from non-small cell lung cancer. |
Volume: |
94 |
|
Pages: |
1-10 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
482
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
424
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1064
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1302
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Rusan M |
Year: |
2018 |
Journal: |
Cancer Discov |
Title: |
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression. |
Volume: |
8 |
Issue: |
1 |
Pages: |
59-73 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alk/Alk Tmem163/Tmem163<+> |
Background: |
involves: 129X1/SvJ * C57BL/6 * C57BL/6N * FVB/N * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alk/Alk Tg(Mpz-cre)94Imeg/? Tg(Th-MYCN)41Waw/? |
Background: |
involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Alk/Alk<+> Tg(Mpz-cre)94Imeg/? Tg(Th-MYCN)41Waw/? |
Background: |
involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Hoareau-Aveilla C |
Year: |
2015 |
Journal: |
J Clin Invest |
Title: |
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. |
Volume: |
125 |
Issue: |
9 |
Pages: |
3505-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giuriato S |
Year: |
2010 |
Journal: |
Blood |
Title: |
Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia. |
Volume: |
115 |
Issue: |
20 |
Pages: |
4061-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kreutmair S |
Year: |
2020 |
Journal: |
J Clin Invest |
Title: |
Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failure. |
Volume: |
130 |
Issue: |
6 |
Pages: |
2827-2844 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hill CR |
Year: |
2015 |
Journal: |
Dev Dyn |
Title: |
Type III transforming growth factor beta receptor regulates vascular and osteoblast development during palatogenesis. |
Volume: |
244 |
Issue: |
2 |
Pages: |
122-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Soda M |
Year: |
2008 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
A mouse model for EML4-ALK-positive lung cancer. |
Volume: |
105 |
Issue: |
50 |
Pages: |
19893-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chiarle R |
Year: |
2003 |
Journal: |
Blood |
Title: |
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. |
Volume: |
101 |
Issue: |
5 |
Pages: |
1919-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Merkel O |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma. |
Volume: |
107 |
Issue: |
37 |
Pages: |
16228-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guillot N |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling. |
Volume: |
7 |
Issue: |
6 |
Pages: |
e39406 |
|
•
•
•
•
•
|
Publication |
First Author: |
Umapathy G |
Year: |
2017 |
Journal: |
Sci Signal |
Title: |
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas. |
Volume: |
10 |
Issue: |
507 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ambrogio C |
Year: |
2005 |
Journal: |
Blood |
Title: |
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. |
Volume: |
106 |
Issue: |
12 |
Pages: |
3907-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dejean E |
Year: |
2011 |
Journal: |
Leukemia |
Title: |
Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. |
Volume: |
25 |
Issue: |
12 |
Pages: |
1882-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maddalo D |
Year: |
2014 |
Journal: |
Nature |
Title: |
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. |
Volume: |
516 |
Issue: |
7531 |
Pages: |
423-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Davare MA |
Year: |
2015 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors. |
Volume: |
112 |
Issue: |
39 |
Pages: |
E5381-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hrustanovic G |
Year: |
2015 |
Journal: |
Nat Med |
Title: |
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer. |
Volume: |
21 |
Issue: |
9 |
Pages: |
1038-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Choudhari R |
Year: |
2016 |
Journal: |
Blood |
Title: |
Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice. |
Volume: |
127 |
Issue: |
10 |
Pages: |
1297-306 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin JJ |
Year: |
2017 |
Journal: |
Cancer Discov |
Title: |
Targeting ALK: Precision Medicine Takes on Drug Resistance. |
Volume: |
7 |
Issue: |
2 |
Pages: |
137-155 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ogura H |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity. |
Volume: |
7 |
Issue: |
1 |
Pages: |
5519 |
|
•
•
•
•
•
|
Publication |
First Author: |
Eleveld TF |
Year: |
2018 |
Journal: |
Cancer Res |
Title: |
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma. |
Volume: |
78 |
Issue: |
21 |
Pages: |
6297-6307 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nikitski AV |
Year: |
2018 |
Journal: |
Am J Pathol |
Title: |
Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion. |
Volume: |
188 |
Issue: |
11 |
Pages: |
2653-2661 |
|
•
•
•
•
•
|
Publication |
First Author: |
Clarke M |
Year: |
2020 |
Journal: |
Cancer Discov |
Title: |
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. |
Volume: |
10 |
Issue: |
7 |
Pages: |
942-963 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rydén M |
Year: |
1996 |
Journal: |
J Biol Chem |
Title: |
A novel type I receptor serine-threonine kinase predominantly expressed in the adult central nervous system. |
Volume: |
271 |
Issue: |
48 |
Pages: |
30603-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hanemaaijer ES |
Year: |
2021 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype. |
Volume: |
118 |
Issue: |
5 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ma L |
Year: |
2016 |
Journal: |
Transl Stroke Res |
Title: |
Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice. |
Volume: |
7 |
Issue: |
6 |
Pages: |
488-496 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang JF |
Year: |
2019 |
Journal: |
Oncogene |
Title: |
Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor. |
Volume: |
38 |
Issue: |
18 |
Pages: |
3428-3445 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mastini C |
Year: |
2023 |
Journal: |
Sci Transl Med |
Title: |
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. |
Volume: |
15 |
Issue: |
702 |
Pages: |
eabo3826 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|